Suppr超能文献

晚期急性原位心脏移植排斥反应的预测因素。

Predictors of late acute orthotopic heart transplant rejection.

作者信息

Winters G L, Costanzo-Nordin M R, O'Sullivan E J, Pifarré R, Silver M A, Zucker M J, Robinson J A, Scanlon P J

机构信息

Department of Pathology, Loyola University Medical Center, Maywood, IL 60153.

出版信息

Circulation. 1989 Nov;80(5 Pt 2):III106-10.

PMID:2805288
Abstract

To identify predictors of late acute rejection after orthotopic heart transplantation (OHT), 53 patients who received transplants between March 1984 and March 1987 and who survived at least 1 year postoperatively were followed up for 402-1,151 days (mean, 841 days). Fourteen patients experienced 22 moderate or severe rejection episodes more than 1 year after OHT (LR); 39 were nonrejectors (NR). Twelve of 14 (86%) LR and only 14 of 39 (36%) NR had two or more moderate or severe rejection episodes within the first year after OHT (p less than 0.001). The LR had significantly higher numbers of infections more than 1 year after OHT (2.0 vs. 0.9; p less than 0.05). Nine of 22 (40%) late acute rejection episodes followed within 1 month of infection. Human leukocyte antigen reactivity before OHT, follow-up hemodynamics, length of survival, incidence of diabetes mellitus, coronary artery disease 1 year after OHT, mean cyclosporine levels, and mean daily prednisone doses were similar in LR and NR patients. We conclude that 1) OHT recipients with two or more moderate or severe rejection episodes in the first year after OHT are at higher risk of developing late acute rejection and may require closer long-term rejection surveillance and more aggressive maintenance immunosuppression and 2) the possible relation between infection and subsequent acute rejection episodes in OHT recipients requires further investigation.

摘要

为了确定原位心脏移植(OHT)后晚期急性排斥反应的预测因素,对1984年3月至1987年3月期间接受移植且术后存活至少1年的53例患者进行了402 - 1151天(平均841天)的随访。14例患者在OHT后1年以上经历了22次中度或重度排斥反应(LR组);39例为无排斥反应者(NR组)。14例LR组患者中有12例(86%)在OHT后的第一年内有两次或更多次中度或重度排斥反应,而39例NR组患者中只有14例(36%)有过此类情况(p<0.001)。LR组在OHT后1年以上的感染次数明显更多(2.0比0.9;p<0.05)。22次晚期急性排斥反应中有9次(40%)发生在感染后1个月内。OHT前的人类白细胞抗原反应性、随访时的血流动力学、存活时间、糖尿病发病率、OHT后1年的冠状动脉疾病、环孢素平均水平以及泼尼松平均每日剂量在LR组和NR组患者中相似。我们得出结论:1)OHT后第一年内有两次或更多次中度或重度排斥反应的受者发生晚期急性排斥反应的风险更高,可能需要更密切的长期排斥反应监测和更积极的维持免疫抑制治疗;2)OHT受者感染与随后急性排斥反应发作之间的可能关系需要进一步研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验